Geneva Advisors buys $82,874,210 stake in Align Technology (ALGN)

Align Technology (ALGN) : Geneva Advisors scooped up 163,577 additional shares in Align Technology during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 8, 2016. The investment management firm now holds a total of 875,771 shares of Align Technology which is valued at $82,874,210.Align Technology makes up approximately 1.59% of Geneva Advisors’s portfolio.

Other Hedge Funds, Including , Blair William Coil boosted its stake in ALGN in the latest quarter, The investment management firm added 1,210 additional shares and now holds a total of 312,283 shares of Align Technology which is valued at $29,551,340. Align Technology makes up approx 0.26% of Blair William Coil’s portfolio.Rs Investment Management Co boosted its stake in ALGN in the latest quarter, The investment management firm added 32,545 additional shares and now holds a total of 601,734 shares of Align Technology which is valued at $51,237,650. Align Technology makes up approx 0.50% of Rs Investment Management Co’s portfolio.Old Mutual Global Investors (uk) Ltd. reduced its stake in ALGN by selling 101,401 shares or 59.3% in the most recent quarter. The Hedge Fund company now holds 69,584 shares of ALGN which is valued at $5,886,111. Align Technology makes up approx 0.11% of Old Mutual Global Investors (uk) Ltd.’s portfolio.

Align Technology opened for trading at $95.62 and hit $96.13 on the upside on Monday, eventually ending the session at $96, with a gain of 0.37% or 0.35 points. The heightened volatility saw the trading volume jump to 6,40,716 shares. Company has a market cap of $7,684 M.

On the company’s financial health, Align Technology reported $0.62 EPS for the quarter, beating the analyst consensus estimate by $ 0.14 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $0.48. The company had revenue of $269.40 million for the quarter, compared to analysts expectations of $258.76 million. The company’s revenue was up 28.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.39 EPS.

Many Wall Street Analysts have commented on Align Technology. Company shares were Reiterated by Stifel on Jul 28, 2016 to “Buy”, Firm has raised the Price Target to $ 95 from a previous price target of $82 .Credit Suisse Initiated Align Technology on May 11, 2016 to “Outperform”, Price Target of the shares are set at $84.

Align Technology Inc. (Align) is a medical device company. The Company designs manufactures and markets a system of clear aligner therapy intra-oral scanners and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services for dentistry orthodontics and dental records storage. The Company operates through two segments: Clear Aligner known as the Invisalign system and Scanners and Services known as the iTero intraoral scanner and OrthoCAD services. The Company’s Clear Aligner segment provides malocclusion and orthodontic treatment. The Company’s Scanners and Services Segment offers iTero intraoral scanner which utilizes laser and optical scanning to capture the contours of the patient’s dentition gingival structures and the bite. It distributes products directly to customers including orthodontists and general practitioner dentists (GPs) as well as to restorative dentists including prosthodontists periodontists and oral surgeons.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *